...
stim-img

Neuronetics Inc, Common Stock

STIM

NMQ

$1.83

+$0.04

(2.23%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$54.90M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
NM
Volume info-icon
This is the total number of shares traded during the most recent trading day.
109.61K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
156.93K
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.31
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.03 L
$5.07 H
$1.83

About Neuronetics Inc, Common Stock

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameSTIMSectorS&P500
1-Week Return-9.41%0.67%0.78%
1-Month Return-25%0.42%2.95%
3-Month Return-57.34%0.84%4.47%
6-Month Return-27.38%9.71%16.17%
1-Year Return-15.67%13.01%27.26%
3-Year Return-89.14%22.89%35.66%
5-Year Return-85.59%70.09%101.24%
10-Year Return-93.41%184.41%234.88%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue62.66M49.24M55.31M65.21M71.35M[{"date":"2019-12-31","value":87.82,"profit":true},{"date":"2020-12-31","value":69.02,"profit":true},{"date":"2021-12-31","value":77.52,"profit":true},{"date":"2022-12-31","value":91.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue15.39M11.55M11.65M15.48M21.65M[{"date":"2019-12-31","value":71.08,"profit":true},{"date":"2020-12-31","value":53.37,"profit":true},{"date":"2021-12-31","value":53.83,"profit":true},{"date":"2022-12-31","value":71.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit47.27M37.69M43.66M49.72M49.70M[{"date":"2019-12-31","value":95.06,"profit":true},{"date":"2020-12-31","value":75.8,"profit":true},{"date":"2021-12-31","value":87.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.95,"profit":true}]
Gross Margin75.44%76.54%78.93%76.26%69.66%[{"date":"2019-12-31","value":95.57,"profit":true},{"date":"2020-12-31","value":96.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.61,"profit":true},{"date":"2023-12-31","value":88.25,"profit":true}]
Operating Expenses74.20M60.00M71.22M84.83M80.25M[{"date":"2019-12-31","value":87.46,"profit":true},{"date":"2020-12-31","value":70.73,"profit":true},{"date":"2021-12-31","value":83.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.6,"profit":true}]
Operating Income(26.93M)(22.31M)(27.56M)(35.11M)(30.55M)[{"date":"2019-12-31","value":-2693000000,"profit":false},{"date":"2020-12-31","value":-2230900000,"profit":false},{"date":"2021-12-31","value":-2756400000,"profit":false},{"date":"2022-12-31","value":-3511100000,"profit":false},{"date":"2023-12-31","value":-3055400000,"profit":false}]
Total Non-Operating Income/Expense(5.80M)(9.67M)(7.65M)(6.30M)(5.04M)[{"date":"2019-12-31","value":-579900000,"profit":false},{"date":"2020-12-31","value":-966600000,"profit":false},{"date":"2021-12-31","value":-764800000,"profit":false},{"date":"2022-12-31","value":-629900000,"profit":false},{"date":"2023-12-31","value":-503500000,"profit":false}]
Pre-Tax Income(29.04M)(27.45M)(31.19M)(37.16M)(30.19M)[{"date":"2019-12-31","value":-2904400000,"profit":false},{"date":"2020-12-31","value":-2745300000,"profit":false},{"date":"2021-12-31","value":-3119300000,"profit":false},{"date":"2022-12-31","value":-3715900000,"profit":false},{"date":"2023-12-31","value":-3018900000,"profit":false}]
Income Taxes5.26M4.82M4.41M2.05M1.00[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":91.78,"profit":true},{"date":"2021-12-31","value":83.89,"profit":true},{"date":"2022-12-31","value":38.96,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(34.30M)(32.28M)(35.60M)(39.21M)(30.19M)[{"date":"2019-12-31","value":-3430000000,"profit":false},{"date":"2020-12-31","value":-3227700000,"profit":false},{"date":"2021-12-31","value":-3560200000,"profit":false},{"date":"2022-12-31","value":-3920700000,"profit":false},{"date":"2023-12-31","value":-3018900100,"profit":false}]
Income From Continuous Operations(29.04M)(27.45M)(31.19M)(37.16M)(30.16M)[{"date":"2019-12-31","value":-2904400000,"profit":false},{"date":"2020-12-31","value":-2745300000,"profit":false},{"date":"2021-12-31","value":-3119300000,"profit":false},{"date":"2022-12-31","value":-3715900000,"profit":false},{"date":"2023-12-31","value":-3016500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(34.30M)(32.28M)(35.60M)(39.21M)(30.19M)[{"date":"2019-12-31","value":-3430000000,"profit":false},{"date":"2020-12-31","value":-3227700000,"profit":false},{"date":"2021-12-31","value":-3560200000,"profit":false},{"date":"2022-12-31","value":-3920700000,"profit":false},{"date":"2023-12-31","value":-3018900000,"profit":false}]
EPS (Diluted)(1.59)(1.41)(1.20)(1.38)(1.07)[{"date":"2019-12-31","value":-159,"profit":false},{"date":"2020-12-31","value":-141,"profit":false},{"date":"2021-12-31","value":-120,"profit":false},{"date":"2022-12-31","value":-138,"profit":false},{"date":"2023-12-31","value":-107,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

STIM
Cash Ratio 3.35
Current Ratio 5.65
Quick Ratio 5.18

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

STIM
ROA (LTM) -15.37%
ROE (LTM) -72.48%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

STIM
Debt Ratio Lower is generally better. Negative is bad. 0.73
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.27
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 3.75

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

STIM
Trailing PE NM
Forward PE NM
P/S (TTM) 1.80
P/B 3.76
Price/FCF NM
EV/R 1.83
EV/Ebitda NM
PEG NM

News

Director Robert Cascella Acquires 50,000 Shares of Neuronetics Inc (STIM)

Director Robert Cascella Acquires 50,000 Shares of Neuronetics Inc (STIM)

7 Jun, 2024 a 6:38 am GuruFocus

Neuronetics to Discuss Future Outlook at Growth Stock Conference

An announcement from Neuronetics (STIM) is now available. Neuronetics, Inc. is set to share its financial and operational outlook at the upcoming W…

6 Jun, 2024 a 11:18 am TipRanks

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the William Blair 44 th Annual Growth Stock Conference on Thursday, June 6, 2024. The Company is scheduled to present at 10:00am Central Time the same day via webcast.

23 May, 2024 a 12:30 pm GlobeNewswire

STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024

Neuronetics (NASDAQ: STIM ) just reported results for the first quarter of 2024. Neuronetics reported earnings per share of -27 cents. This was above the analyst estimate for EPS of -31 cents. The company reported revenue of $17.42 million. This was 1.73% better than the analyst estimate for revenue of $17.12 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million.

7 May, 2024 a 3:53 pm InvestorPlace

Neuronetics Inc (STIM) Reports Q1 2024 Earnings: Revenue Surpasses Estimates, Narrowing Losses

Neuronetics Inc (STIM) Reports Q1 2024 Earnings: Revenue Surpasses Estimates, Narrowing Losses

7 May, 2024 a 12:58 pm GuruFocus

Neuronetics Inc Releases New Investor Presentation for May 2024

Neuronetics Inc (STIM) has shared an update. Neuronetics, Inc. has updated its investor relations page with a fresh investor presentation and addit…

7 May, 2024 a 11:42 am TipRanks

Neuronetics: Q1 Earnings Snapshot

MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Neuronetics Inc. (STIM) on Tuesday reported a loss of $7.9 million in…

7 May, 2024 a 11:39 am WTOP

FAQs

What is Neuronetics Inc share price today?

Neuronetics Inc (STIM) share price today is $1.83

Can Indians buy Neuronetics Inc shares?

Yes, Indians can buy shares of Neuronetics Inc (STIM) on Vested. To buy Neuronetics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in STIM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Neuronetics Inc be purchased?

Yes, you can purchase fractional shares of Neuronetics Inc (STIM) via the Vested app. You can start investing in Neuronetics Inc (STIM) with a minimum investment of $1.

How to invest in Neuronetics Inc shares from India?

You can invest in shares of Neuronetics Inc (STIM) via Vested in three simple steps:

  • Click on Sign Up or Invest in STIM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Neuronetics Inc shares
What is Neuronetics Inc 52-week high and low stock price?

The 52-week high price of Neuronetics Inc (STIM) is $5.07. The 52-week low price of Neuronetics Inc (STIM) is $1.03.

What is Neuronetics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Neuronetics Inc (STIM) is NM

What is Neuronetics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Neuronetics Inc (STIM) is 3.76

What is Neuronetics Inc dividend yield?

The dividend yield of Neuronetics Inc (STIM) is 0.00%

What is the Market Cap of Neuronetics Inc?

The market capitalization of Neuronetics Inc (STIM) is $54.90M

What is Neuronetics Inc’s stock symbol?

The stock symbol (or ticker) of Neuronetics Inc is STIM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top